Press Releases Events & Presentations Event Details ABI-1179 and ABI-5366 Interim Phase 1b Results Update Dec 8, 2025 at 6:00 PM EST Listen to webcast Supporting Materials Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 in Recurrent Genital Herpes 782.3 KB Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
ABI-1179 and ABI-5366 Interim Phase 1b Results Update Dec 8, 2025 at 6:00 PM EST Listen to webcast Supporting Materials Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 in Recurrent Genital Herpes 782.3 KB
Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 in Recurrent Genital Herpes 782.3 KB
